GPT and metabolic dysfunction-associated steatotic liver disease: The activities of hepatic markers, such as AST, ALT and GGT, were in accordance with previously reported data, which indicate that ALT is commonly increased in NAFLD patients [49], and the AST/ALT ratio is below 0.8 in these patients [50].